Literature DB >> 7000423

Prostacyclin-like activity in the female rat thoracic aorta and the inferior vena cava after ethinyloestradiol and norethisterone.

L Karpati, F P Chow, M L Woollard, R A Hutton, P Dandona.   

Abstract

1. Female rats were injected with ethinyloestradiol, norethisterone or both compounds for 30 days. Prostacyclin-like activity was measured in the thoracic aorta and inferior vena cava. 2. In the thoracic aorta of rats injected with ethinyloestradiol and ethinyloestradiol/norethisterone, prostacyclin-like activity was significantly increased. Norethisterone alone had no effect. 3. In the inferior vena cava of rats injected with ethinyloestradiol, norethisterone or both compounds, prostacyclin-like activity was not significantly altered. The amount of prostacyclin generated by the inferior vena cava was much lower than that by the aorta. 4. Experimentally induced changes in the vessel wall after the administration of contraceptive steroids must be due to factors other than diminished prostacyclin production.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000423     DOI: 10.1042/cs0590369

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

1.  Platelet aggregation in pregnancy.

Authors:  P Dandona; R H Hutton; F P Chow; I L Craft
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

2.  Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.

Authors:  T Hayashi; J M Fukuto; L J Ignarro; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  Papillary plasma flow in rats. II. Hormonal control.

Authors:  L Eloy; J P Grünfeld; F Bayle; L Bankir; B Ramos-Frendo; M M Trinh-Trang-Tan
Journal:  Pflugers Arch       Date:  1983-08       Impact factor: 3.657

4.  The effect of synthetic ovarian hormones on an in vivo model of thrombosis in the rat.

Authors:  H Emms; G P Lewis
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.